DK116390D0 - Accellerering af knogledannelse med gm-csf - Google Patents

Accellerering af knogledannelse med gm-csf

Info

Publication number
DK116390D0
DK116390D0 DK116390A DK116390A DK116390D0 DK 116390 D0 DK116390 D0 DK 116390D0 DK 116390 A DK116390 A DK 116390A DK 116390 A DK116390 A DK 116390A DK 116390 D0 DK116390 D0 DK 116390D0
Authority
DK
Denmark
Prior art keywords
csf
acceleration
bone creation
bone
creation
Prior art date
Application number
DK116390A
Other languages
English (en)
Other versions
DK116390A (da
Inventor
Hugh E Black
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK116390A publication Critical patent/DK116390A/da
Publication of DK116390D0 publication Critical patent/DK116390D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK116390A 1987-11-12 1990-05-10 Accellerering af knogledannelse med gm-csf DK116390D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11961187A 1987-11-12 1987-11-12
PCT/US1988/003922 WO1989004173A1 (en) 1987-11-12 1988-11-10 Acceleration of bone formation with gm-csf

Publications (2)

Publication Number Publication Date
DK116390A DK116390A (da) 1990-05-10
DK116390D0 true DK116390D0 (da) 1990-05-10

Family

ID=22385326

Family Applications (1)

Application Number Title Priority Date Filing Date
DK116390A DK116390D0 (da) 1987-11-12 1990-05-10 Accellerering af knogledannelse med gm-csf

Country Status (6)

Country Link
EP (2) EP0318184A1 (da)
JP (1) JPH0649655B2 (da)
AU (1) AU638204B2 (da)
DK (1) DK116390D0 (da)
IL (1) IL88344A (da)
WO (1) WO1989004173A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69001686T2 (de) * 1989-01-30 1993-09-02 Schering Corp Behandlung von leukozytstoerungen mit gm-csf.
NZ236618A (en) * 1990-01-03 1997-06-24 Ciba Geigy Ag Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
JPH0517367A (ja) * 1991-07-08 1993-01-26 Green Cross Corp:The 骨粗鬆症治療剤
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
DK0988871T3 (da) * 1991-12-18 2004-05-24 Icu Medical Inc Fremgangsmåde til overføring af fluid
TW267102B (da) 1992-03-13 1996-01-01 Ciba Geigy
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
EP0891779A1 (de) * 1997-06-19 1999-01-20 Roche Diagnostics GmbH Pharmazeutische Kombinationspräparate enthaltend Parathyroidhormon und Calcium- und/oder Phosphatverbindungen
JP4709440B2 (ja) * 2001-08-20 2011-06-22 高山産業株式会社 通気路形成用のスペーサーおよびそのスペーサーを用いた壁体の通気路形成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR893138A (fr) * 1940-04-05 1944-05-31 Procédé de préparation d'un produit destiné à guérir les fractures des os
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
AU626530B2 (en) * 1987-07-17 1992-08-06 Schering Biotech Corporation Human granulocyte-macrophage colony stimulating factor and muteins thereof

Also Published As

Publication number Publication date
EP0386109A1 (en) 1990-09-12
WO1989004173A1 (en) 1989-05-18
JPH0649655B2 (ja) 1994-06-29
IL88344A0 (en) 1989-06-30
DK116390A (da) 1990-05-10
AU638204B2 (en) 1993-06-24
IL88344A (en) 1994-06-24
AU2710388A (en) 1989-06-01
JPH02502642A (ja) 1990-08-23
EP0318184A1 (en) 1989-05-31

Similar Documents

Publication Publication Date Title
DK208188D0 (da) Anvendelse af 17-ketosteroider
FR2583635B1 (fr) Instrument porte-prothese
DK238988D0 (da) Fremgangsmaade til fremstilling af 4-acyloxy-3-hydroxyethyl-azetidinoner
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
DK193588A (da) Anvendelser af dopaminagonister
DK363887D0 (da) Anvendelse af bromcruptin
FI88164C (fi) Metalljonskelat med en kelaterande dipyridoxalfosfatfoerening
DK468888D0 (da) Fremgangsmaade til fresmtilling af keramiske pulvere
FI925528L (fi) Nya karbamater
DK116390D0 (da) Accellerering af knogledannelse med gm-csf
DK584288A (da) Fremgangsmaade til fremstilling af guaninderivater
DK549688D0 (da) Fremstilling af peptider
DK185988A (da) Anvendelse af antigen
DK270988A (da) Nitrogenholdige derivater af epipodophyllotoxinglucosider
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
DK28788D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK562289D0 (da) Anvendelse af somatostatiner
DK237385A (da) Anvendelse af dihydroergotamin
DK105089D0 (da) Fremstilling af bis(amin-holdige)benzendioler
DK305089D0 (da) Lewis-basekomplekser af alkalimetalsalte
KR880021636U (ko) 샤아프펜슬의 유니트블럭부재
DK98290D0 (da) Bencement med indhold af vaekststimulerende midler
DK689388A (da) Anvendelse af dihydropyridinderivater
DK163830C (da) Fremgangsmaade til fremstilling af riboflavin
DK512687D0 (da) Fremstilling af proteiner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment